UK commits to pharma IP protection in Swiss trade deal - Pharmaceutical Technology

The pharma industry welcomed the pledge, which marked the first-time drug IP has explicitly been stated in a free trade agreement The pharma industry welcomed the pledge, which marked the first-time drug IP has explicitly been stated in a free trade agreement The agreement is of note given the size of the pharmaceutical sectors in each country. Credit: Lensw0rId/Shutterstock.com. The UK government has committed to maintaining its existing intellectual property (IP) framework for pharmaceuticals as part of a new trade deal with Switzerland. The agreement locks in place IP protections in the UK and Switzerland, meaning neither country will be…

Source: Pharmaceutical Technology